Literature DB >> 1741545

Correlation of clinical and immunologic parameters of the inflammatory activity of pulmonary sarcoidosis.

J Müller-Quernheim1, S Pfeifer, J Strausz, R Ferlinz.   

Abstract

The evaluation of activation markers such as T4/T8 ratio and HLA-DR expression of lymphocytes of bronchoalveolar lavage (L-BAL) is an important clinical approach for the staging of sarcoidosis. However, it is not known to what extent this is paralleled by an exaggerated lymphocyte function. We investigated the dependence of L-BAL activation markers on the production of interleukin-2 (IL-2) by L-BAL and on the soluble IL-2 receptor serum level (sIL-2R) in 116 patients with sarcoidosis. In none of the combinations tested was a correlation between the two groups of parameters found; r less than 0.5, upper 90% confidence limit of r less than 0.8. Interestingly, IL-2 production is independent of HLA-DR+ T4 L-BAL, and sIL-2R production is independent of the percentage of IL-2+ L-BAL. Our data indicate that the L-BAL activation markers and the functional activity of T-cells represent independent phenomena.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1741545     DOI: 10.1164/ajrccm/144.6.1322

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  14 in total

1.  Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells.

Authors:  A Prasse; C G Georges; H Biller; H Hamm; H Matthys; W Luttmann; J C Virchow
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

2.  Biological role of the soluble interleukin-2 receptor in sarcoidosis.

Authors:  Remi M M Vanmaris; Ger T Rijkers
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

3.  Analysis of T cell subsets and beta chemokines in patients with pulmonary sarcoidosis.

Authors:  K Iida; J Kadota; K Kawakami; Y Matsubara; R Shirai; S Kohno
Journal:  Thorax       Date:  1997-05       Impact factor: 9.139

4.  Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosis.

Authors:  Hela-Felicitas Petereit; Dirk Reske; Hayrettin Tumani; Sven Jarius; F Markus Leweke; Dirk Woitalla; Hans-Walter Pfister; Andrea Rubbert
Journal:  J Neurol       Date:  2010-06-17       Impact factor: 4.849

5.  Evaluation of soluble CD 14 and neopterin as serum parameters of the inflammatory activity of pulmonary sarcoidosis.

Authors:  J Homolka; J Lorenz; H D Zuchold; J Müller-Quernheim
Journal:  Clin Investig       Date:  1992-10

Review 6.  Clinical and immunologic components of sarcoidosis.

Authors:  Andrea T Borchers; Calvin So; Stanley M Naguwa; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2003-12       Impact factor: 8.667

7.  Spontaneous interleukin 2 release of bronchoalveolar lavage cells in sarcoidosis is a codeterminator of prognosis.

Authors:  J Müller-Quernheim; S Pfeifer; K Kienast; G Zissel
Journal:  Lung       Date:  1996       Impact factor: 2.584

Review 8.  Sarcoidosis and the heart: A review of the literature.

Authors:  Emrah Ipek; Selami Demirelli; Emrah Ermis; Sinan Inci
Journal:  Intractable Rare Dis Res       Date:  2015-11

9.  Specification and quantitation of circulating immune complexes in the serum of patients with active pulmonary sarcoidosis.

Authors:  N Schoenfeld; B Schmolke; M Schmitt; N Remy; P Ellensohn; U Wahn; R Loddenkemper
Journal:  Thorax       Date:  1994-07       Impact factor: 9.139

Review 10.  Serum biomarkers in interstitial lung diseases.

Authors:  Argyris Tzouvelekis; George Kouliatsis; Stavros Anevlavis; Demosthenes Bouros
Journal:  Respir Res       Date:  2005-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.